Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-4.94%
trims when stocks drop
when a holding falls −10%+
Middle response
-2.69%
baseline attrition
Rally response
-6.23%
trims into rallies
when a holding rises +10%+
Top positions · 8
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| GLUEMonte Rosa Therapeutics, | $52M | 37.0% | +254.5% | 1.5 yr |
| IPSCCentury Therapeutics, In | $27M | 19.4% | +374.8% | 0.3 yr |
| LENZLENZ Therapeutics, Inc. | $24M | 17.2% | -64.4% | 0.8 yr |
| JBIOJade Biosciences, Inc. | $21M | 15.2% | — | 1.0 yr |
| CTNMContineum Therapeutics, | $7M | 5.0% | +87.1% | 2.0 yr |
| CRSPCRISPR Therapeutics AG | $7M | 5.0% | +39.8% | 8.3 yr |
| — | $1M | 0.9% | — | 2.3 yr |
| — | $0M | 0.3% | — | 1.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology98.8%+4.1pp$140M
Unknown1.2%-4.1pp$2M
Country
US93.8%+31.6pp
CH5.0%-23.2pp
Unknown1.2%-4.1pp
Top 5: 93.8% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 1
| IPSC Century Therapeutics, Inc.new | +$27M |
Top sells this quarter · 1
| GLUE Monte Rosa Therapeutics, Inc. | −$20M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141M | 8 | +28.71% | +17.59% | +11.11% | -0.00B |
| 2025-12-31 | $151M | 7 | -6.21% | +17.72% | -23.93% | -0.03B |
| 2025-09-30 | $212M | 9 | +1.97% | +17.52% | -15.55% | +0.09B |
| 2025-06-30 | $82M | 8 | -33.88% | +14.94% | -48.82% | +0.02B |
| 2025-03-31 | $60M | 7 | -68.06% | +8.30% | -76.36% | +0.00B |
| 2024-12-31 | $87M | 7 | -39.35% | +24.89% | -64.23% | +0.03B |
| 2024-09-30 | $64M | 6 | -31.90% | +36.04% | -67.94% | -0.01B |
| 2024-06-30 | $77M | 8 | -43.73% | +24.49% | -68.22% | +0.02B |
| 2024-03-31 | $103M | 7 | +24.71% | +29.62% | -4.92% | -0.40B |
| 2023-12-31 | $389M | 7 | -7.02% | +26.18% | -33.20% | +0.19B |
| 2023-09-30 | $188M | 7 | -40.64% | +21.57% | -62.20% | +0.12B |
| 2023-06-30 | $84M | 8 | -48.15% | +19.42% | -67.57% | +0.03B |
| 2023-03-31 | $48M | 7 | -75.48% | -7.82% | -67.66% | +0.00B |
| 2022-12-31 | $48M | 7 | -32.52% | +7.56% | -40.08% | +0.01B |
| 2022-09-30 | $59M | 8 | -31.34% | -4.93% | -26.41% | +0.01B |
| 2022-06-30 | $65M | 8 | -45.51% | -16.11% | -29.40% | +0.01B |